Second, demographic and symptom data for patients who started an assessment during the comparison period (n = 1650) and the early COVID-19 period (n = 1668) were compared. Third, responses to questions about the impact of COVID-19 introduced to the assessment from 19 March 2020, and reports from treating therapists were examined.